07 Jan 2001

Cholipin 20 - España

Updated: 07 Jan 2001

Cholipin 20 grageas

Disquinesias biliares, espasmos biliares. Síndrome post-colecistectomía. Dispepsias por alteración de la secreción biliar. Litiasis biliar no obstructiva.

Cholipin 20 Description, Presentation and Dosage

Cholipin 20 Description

Cholipin 20 Drug Class Description

Colagogos y colereticos en asociacion salvo a05c

Cholipin 20 Drug Description

GRAGEAS

Cholipin 20 Presentation

Cholipin 20 Presentation

1-2 grageas 3 veces al día, preferentemente antes de las comidas.

Cholipin 20 Manufacturer

BOEHRINGER INGELHEIM

Related Learning Zones

CLL Knowledge Centre and CME

CLL Knowledge Centre and CME

The Chronic Lymphocytic Leukaemia (CLL) Knowledge Centre contains useful information arranged within four main sections: ‘Disease Awareness’, ‘Events’, ‘Resources’, and 'CME'. Healthcare professionals will find information on pathophysiology, signs and symptoms of CLL, diagnosis, prognosis, treatment and management options, an upcoming events calendar and an external links listing,

The CME activity ‘Treatment Optimisation in Chronic Lymphocytic Leukaemia’ has been EACCME-accredited and awarded 1 CME credit. Test your knowledge by answering quiz questions based on patient case study scenarios.

Prostate Cancer Learning Hub

Prostate Cancer Learning Hub

The Prostate Cancer Learning Hub has been designed with the busy healthcare professional in mind. The resource conveniently organises a range of up-to-date education content, reference materials and decision support tools, all focussing on prostate cancer. The disease awareness section provides you with access to a Prostate Cancer Knowledge Centre, which has been developed to provide you with easy to digest best practice guidance for the treatment and management of patients with prostate cancer.

Cholipin 20 Dosage

Cholipin 20 Precautions, Reactions and Contraindications

Cholipin 20 Special Precautions

Related Drugs - Gastroenterologia

Back to top